Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 1.00 |
| ▸ | CA2 | P00918 | 7/20 | 1.00 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MMP7 | P09237 | 3/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | MMP10 | P09238 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 2/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15621568 | 0.89 | CA1 (0.79) | CA1CA2MMP7MMP9MMP10 | |
| SCHEMBL6324136 | 0.86 | CA1 (0.75) | CA1CA2CA12CA9MMP7 | |
| SCHEMBL30800478 | 0.81 | CA2 (0.75) | CA1CA2CA12CA9CYP19A1 | |
| SCHEMBL27000224 | 0.79 | CA1 (0.66) | CA1CA2CA12CA9MMP7 | |
| SCHEMBL16508905 | 0.77 | CA1 (0.62) | CA1CA2CA12CA9MMP7 | |
| SCHEMBL30800487 | 0.76 | CA2 (0.67) | CA1CA2CA12CA9MMP9 | |
| SCHEMBL12377249 | 0.76 | CA1 (0.61) | CA1CA2MMP7MMP9MMP10 | |
| SCHEMBL5273382 | 0.76 | CA1 (0.60) | CA1CA2MMP7MMP9MMP10 | |
| SCHEMBL16934367 | 0.75 | MMP1 (0.68) | CA1CA2CA12CA9MMP7 | |
| SCHEMBL16508871 | 0.74 | CA1 (0.59) | CA1CA2CA12CA9MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIV POITIERS (FR) | 2026-05-07 | — | — | US | disclosed |
| EP-4598903-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | Université de Poitiers (FR) | 2025-08-13 | — | — | EP | disclosed |
| CN-120035579-A | Process for fluorinating and/or cyclizing an amino alkene or alkyne in a continuous flow and apparatus for carrying out the process | 普瓦捷大学 | 2025-05-23 | — | — | CN | disclosed |
| WO-2024074501-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIVERSITE DE POITIERS (FR) | 2024-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | FIBP, FGB, SUB1 | CA1 382/4885CA2 332/4885CA12 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.